|
|
News Breaks | | | | March 14, 2013 | | 09:05 EDT |  | SURG | Synergetics sell-off overdone, says Stephens
After Synergetics reported much weaker than expected 2013 operating results, Stephens still believes that the commercial potential of its new product portfolio is compelling. The firm lowered its price target on the stock to $5 from $7 and expects the shares to remain challenged for the rest of the company's fiscal year but maintains an Overweight rating. | |
|
News For SURG From The Last 14 Days Check below for free stories on SURG the last two weeks. |
|
|
| There are no results for SURG |
|
|
|
|
|
|
